LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...
The uniformity of delivered dose, or dose content uniformity, was assessed to understand the performance of the Sirdupla generic product versus the Seretide Evohaler innovator product. Analytical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback